Heart Rate Controller in Computed Tomography Coronary Angiography
Launched by MAHIDOL UNIVERSITY · Feb 28, 2022
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
Coronary computed tomography angiography (CCTA) is one of important non-invasive test for diagnosis coronary artery disease. Information of CCTA can provide information such as coronary artery lumen, vessel wall, degree of stenosis and component of coronary arterial plaque. Most of studies in CCTA represent high negative predictive value (NPV) approximately 93-100 %.However, motion artifact has impact on CCTA interpretation, especially when heart rate (HR) at more than 70 beat-per-minute (bpm). Therefore, HR reduction maneuver is necessary for CCTA. Current recommendation suggests HR reduct...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age of at least 18 year-old
- • 2. Received Coronary CT angiography at Siriraj Hospital to evaluate diagnosis of coronary artery disease or risk stratification of coronary artery disease
- • 3. Normal sinus rhythm with baseline HR \> 60 bpm which cardiac imaging specialist suggest using HR lowering intervention
- Exclusion Criteria:
- • 1. Atrial fibrillation
- • 2. Previous pacemaker implantation
- • 3. II- and III-degree atrio-ventricular-block
- • 4. NHYA class III - IV
- • 5. Documented LVEF \< 40%
- • 6. Contraindication for CCTA: Impaired renal function (serum creatinine \> 1.5 mg/dl), known allergy to iodinated contrast media, pregnancy, thyroid disease
- • 7. Blood pressure \< 100/70 mmHg
- • 8. Uncontrolled asthma and/or chronic obstructive pulmonary disease (defined as GOLD stage D) and/or uncontrolled reactive airway disease
- • 9. Current medication which cause severe interaction with calcium channel blocker, beta blocker and/or Ivabradine
- • 10. Known allergy to calcium channel blocker, beta blocker and/or Ivabradine
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, Bangkoknoi, Thailand
Patients applied
Trial Officials
Prichapol Thantassanee, M.D.
Principal Investigator
Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital Mahidol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials